0.00Open0.00Pre Close0 Volume0 Open Interest88.00Strike Price0.00Turnover2300.84%IV-9.36%PremiumDec 6, 2024Expiry Date7.53Intrinsic Value100Multiplier-5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9864Delta0.0081Gamma--Leverage Ratio-32.1002Theta0.0000Rho0.00Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet